GSK3β overexpression driven by GFAP promoter improves rotarod performance.


Journal

Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 07 11 2018
revised: 28 01 2019
accepted: 30 01 2019
pubmed: 4 2 2019
medline: 12 9 2020
entrez: 4 2 2019
Statut: ppublish

Résumé

We have studied the consequences of in vivo GSK3β overexpression in the cerebellum using transgenic mice with conditional expression where the transactivator tTA protein expression is driven by GFAP promoter. We demonstrate an increase in GSK3β in Bergmann cells. To study cerebellar dysfunctions and evaluate motor coordination we analysed the latency to fall in the accelerating rotarod test. GSK3β transgenic mice performed significantly better than wild-type mice and transgene shutdown with doxycycline normalizes the values in latency to fall in rotarod test. We had previously demonstrated using the same transgenic model, that overexpression of GSK3β in the hippocampus results in an increase in neural precursor cells. However, we did not observe that increase in the number of Sox2+ cells in the cerebellum. All the same, we observed an increase in cerebellar glutamate transporters GLT1 and GLAST. These data show that GSK3β can be a crucial kinase in cerebellum and especially in Bergmann glial cells.

Identifiants

pubmed: 30711399
pii: S0006-8993(19)30065-4
doi: 10.1016/j.brainres.2019.01.040
pii:
doi:

Substances chimiques

Amino Acid Transport System X-AG 0
Glial Fibrillary Acidic Protein 0
Trans-Activators 0
glial fibrillary astrocytic protein, mouse 0
Glycogen Synthase Kinase 3 beta EC 2.7.11.1
Gsk3b protein, mouse EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-54

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Jerónimo Jurado-Arjona (J)

Centro de Biología Molecular "Severo Ochoa", CSIC/UAM, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain; CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, 28031 Madrid, Spain. Electronic address: jjurado@uni-mainz.de.

Alberto Rodríguez-Matellán (A)

Centro de Biología Molecular "Severo Ochoa", CSIC/UAM, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain; CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, 28031 Madrid, Spain.

Jesús Ávila (J)

Centro de Biología Molecular "Severo Ochoa", CSIC/UAM, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain; CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, 28031 Madrid, Spain.

Félix Hernández (F)

Centro de Biología Molecular "Severo Ochoa", CSIC/UAM, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain; CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, 28031 Madrid, Spain. Electronic address: fhernandez@cbm.csic.es.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH